BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17500)

  • 1. Methadone maintenance: effect of urinary pH on renal clearance in chronic high and low doses.
    Bellward GD; Warren PM; Howald W; Axelson JE; Abbott FS
    Clin Pharmacol Ther; 1977 Jul; 22(1):92-9. PubMed ID: 17500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state pharmacokinetics of methadone maintenance patients: renal clearance in low vs high dosages.
    Bellward GD
    Proc West Pharmacol Soc; 1977; 20():483-5. PubMed ID: 19769
    [No Abstract]   [Full Text] [Related]  

  • 3. The secretion of methadone and its major metabolite in the gastric juice of humans: comparison with blood and salivary concentrations.
    Lynn RK; Olsen GD; Leger RM; Gordon WP; Smith RG; Gerber N
    Drug Metab Dispos; 1976; 4(5):504-9. PubMed ID: 10151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone disposition in patients with chronic liver disease.
    Novick DM; Kreek MJ; Fanizza AM; Yancovitz SR; Gelb AM; Stenger RJ
    Clin Pharmacol Ther; 1981 Sep; 30(3):353-62. PubMed ID: 7273599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of methadone.
    Nilsson MI; Meresaar U; Anggård E
    Acta Anaesthesiol Scand Suppl; 1982; 74():66-9. PubMed ID: 6953740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of urinary pH on the disposition of methadone in man.
    Nilsson MI; Widerlöv E; Meresaar U; Anggård E
    Eur J Clin Pharmacol; 1982; 22(4):337-42. PubMed ID: 6286317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolites of dl-methadone in maintenance subjects.
    Sullivan HR; Due SL
    J Med Chem; 1973 Aug; 16(8):909-13. PubMed ID: 4745834
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition of methadone in man after a single oral dose.
    Inturrisi CE; Verebely K
    Clin Pharmacol Ther; 1972; 13(6):923-30. PubMed ID: 5081605
    [No Abstract]   [Full Text] [Related]  

  • 9. Disposition of methadone in methadone maintenance.
    Anggård E; Gunne LM; Homstrand J; McMahon RE; Sandberg CG; Sullivan HR
    Clin Pharmacol Ther; 1975 Mar; 17(3):258-66. PubMed ID: 1120392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered methadone pharmacokinetics in methadone-maintained pregnant women.
    Pond SM; Kreek MJ; Tong TG; Raghunath J; Benowitz NL
    J Pharmacol Exp Ther; 1985 Apr; 233(1):1-6. PubMed ID: 3981450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of severe alcoholic liver disease on the disposition of methadone in maintenance patients.
    Novick DM; Kreek MJ; Arns PA; Lau LL; Yancovitz SR; Gelb AM
    Alcohol Clin Exp Res; 1985; 9(4):349-54. PubMed ID: 3901806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.
    Tennant F; Shannon J
    J Addict Dis; 1995; 14(1):67-74. PubMed ID: 7632748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase.
    Nilsson MI; Anggård E; Holmstrand J; Gunne LM
    Eur J Clin Pharmacol; 1982; 22(4):343-9. PubMed ID: 7106170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver damage indices as a tool for modifying methadone maintenance treatment: a cross-sectional study.
    Ključević Ž; Benzon B; Ključević N; Veršić Bratinčević M; Sutlović D
    Croat Med J; 2018 Dec; 59(6):298-306. PubMed ID: 30610772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone-disulfiram interaction during methadone maintenance.
    Tong TG; Benowitz NL; Kreek MJ
    J Clin Pharmacol; 1980; 20(8-9):506-13. PubMed ID: 7430415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting.
    Kell MJ
    J Addict Dis; 1994; 13(1):5-26. PubMed ID: 8018740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures.
    Nilsson MI; Grönbladh L; Widerlöv E; Anggård E
    Eur J Clin Pharmacol; 1983; 25(4):497-501. PubMed ID: 6653644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.
    Berkowitz BA
    Clin Pharmacokinet; 1976; 1(3):219-30. PubMed ID: 13957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and urine levels of methadone. Comparison following four medication forms used in chronic maintenance treatment.
    Kreek MJ
    N Y State J Med; 1973 Dec; 73(23):2773-7. PubMed ID: 4520357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.